Genenta Science S.p.A.
Genenta Science S.p.A. (GNTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNTA · as of Jun 9, 2026
Key Statistics
Explore Genenta Science S.p.A. Data
gnta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
gnta competitorsGNTA
BRNS
CVM
INMB
IPSC
JUNSStock Performance
Full HistoryAbout Genenta Science S.p.A.
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon,…
what is genenta science s.p.a. · gnta stock overview · genenta science s.p.a. company profile · who is genenta science s.p.a. ceo · gnta NASDAQ · genenta science s.p.a. headquarters · genenta science s.p.a. business segments
About Stock Overview & Key Data
Genenta Science S.p.A. (GNTA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 15, 2021. As of the latest trading session, GNTA stock price is $1.80, with a market capitalization of $34.5M. The stock has returned -55.00% over the past 12 months and +20.81% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Genenta Science S.p.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Genenta Science S.p.A. reported revenue of — and net income of -$6.3M. For detailed data — including Genenta Science S.p.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genenta Science S.p.A. (GNTA) stock price is $1.80. The stock is traded on NASDAQ under the ticker symbol GNTA. The 52-week range is $0.55 – $10.00.